Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
23 Oct 24 | APRE Aprea Therapeutics | Common Stock | Buy | Acquire P | No | No | 3.915 | 500 | 1.96 k | 333,395 |
15 Oct 24 | APRE Aprea Therapeutics | Common Stock | Buy | Acquire P | No | No | 2.9 | 250 | 725.00 | 332,895 |
14 Oct 24 | APRE Aprea Therapeutics | Common Stock | Buy | Acquire P | No | No | 2.59 | 1,000 | 2.59 k | 332,645 |
10 Oct 24 | APRE Aprea Therapeutics | Common Stock | Buy | Acquire P | No | No | 2.54 | 150 | 381.00 | 331,645 |
28 Mar 24 | APRE Aprea Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 6,725 | 0.00 | 331,495 |
28 Mar 24 | APRE Aprea Therapeutics | Stock Options Common Stock | Grant | Acquire A | No | No | 6.69 | 26,900 | 179.96 k | 26,900 |
13 Mar 24 | APRE Aprea Therapeutics | Common Stock | Buy | Acquire P | No | No | 7.29 | 2,000 | 14.58 k | 324,770 |
13 Mar 24 | APRE Aprea Therapeutics | Tranche B Warrant Common Stock | Buy | Acquire P | No | No | 0 | 1,000 | 0.00 | 1,000 |
13 Mar 24 | APRE Aprea Therapeutics | Tranche A Warrant Common Stock | Buy | Acquire P | No | No | 0 | 1,000 | 0.00 | 1,000 |